Working Group 3 Members - Histamine H4 Receptor

NAME Institution
Working Group 3 Members
e-mail Expertise
1. Adami Maristella University of Parma, IT adamfarm@unipr.it Gastric Acid Secretion;
2. Alfon Coriat Jose Palau Pharma SA,
Barcelona, ES
3. Buschauer Armin University of
Regensburg, DE
Gastric Ulcer
jalfon@palaupharma.com Drug Discovery &
Development; Respiratory
armin.buschauer@chemie.un
i-regensburg.de
research; Immunology
Medical chemistry of
selective histamine receptor
ligands
4. Chazot Paul Durham University, UK paul.chazot@dur.ac.uk Novel drug targets for CNS
pathologies
5. Coruzzi Gabriella University of Parma, IT gabriella.coruzzi@unipr.it Histamine receptor in the
6. Dymek Anna Jagiellonian University
Medical College, PL
7. Ennis Madeleine The Queen's University
of Belfast, UK
8. Falus Andras Semmelweis University,
Budapest, HU
9. Geyer Roland University of
Regensburg, DE
10. Handzlik Jadwiga Jagiellonian University
Medical College,
Krakow, PL
gastrointestinal tract
annadymek1@wp.pl H3R & H4R pharmacology
m.ennis@qub.ac.uk Respiratory disease;
Translational Research;
Clinical Trials
faland@dgci.sote.hu Immunogenetics
Roland.Geyer@chemie.uniregensburg.de
Synthesis, pharmacological
characterization of H4R
agonists
jhandzli@cm-uj.krakow.pl Design & synthesis of
active pharmaceutical
ingredients; Hydantoin &
piperazine derivatives
11. Hofstra L. Claudia MSD, Oss, NL claudia.hofstra@spcorp.com Immunology
12. Hultgren Hornquist Orebro University, SE elisabeth.hultgren-
Mucosal Immunology;
Elisabeth
hornquist@oru.se
Spontaneous colitis
13. Igel Patrick University of
patrick.igel@chemie.uni- Design, synthesis &
Regensburg, DE regensburg.de
pharmacological
investigation of H4R ligands
14. Irman Florjanc University of Ljubljana, tatjana.irman-
Histamine
Tatjana
SI
florjanc@mf.uni-lj.si
pharmacokinetics;
Astrocytes; Cultured
umbilical vein endothelial
cells & peritoneal mast cells
15. Istyastono Enade VU University
epo200@few.vu.nl Computational medicinal
Perdana
Amsterdam, NL
chemistry: QSAR, docking &
virtual screening to design
selective H4R ligands
16. Kiec- Kononowicz Jagiellonian University mfkonono@cyf-kr.edu.pl Medicinal chemistry; drug
Katarzyna
Medical College,
design & synthesis,
Krakow, PL
physicochemical properties;
Molecular modeling;
Pharmaceutical
biotechnology
17. Kuder J. Kamil Jagiellonian University kkuder@cm-uj.krakow.pl Synthesis, physicochemical
Medical College,
properties & molecular
Krakow, PL
modeling of H3R & H4R
ligands
18. Kumawat Ashok Orebro University, SE ashok.kumawat@oru.se Mucosal Immunology;
Kumar
Microscopic Colitis
[1] - 6.4.2010 – WG3 Members

19. Kyriakidis Dimitrios Aristotle University of
Thessaloniki, GR
20. Lazewska Dorota Jagiellonian University
Medical College,
Krakow, PL
21. Leurs Rob VU University
Amsterdam, NL
22. Masłowska –
Lipowicz Iwona
23. Medina Torres
Miguel Angel
24. Moya-Garcia A.
Aurelio
Medical University of
Lodz, PL
Universidad de Malaga,
ES
Universidad de Malaga,
ES
25. Nosalova Viera Slovak Academy of
Sciences, Bratislava, SK
kyr@eie.gr Histamine-polyamine
interplay on enzyme
mflazews@cyf-kr.edu.pl
function & gene expression
Synthesis of H3R & H4R
compounds
leurs@mac.com Medical Chemistry &
molecular pharmacology of
histamine receptors & their
iwona.maslowskalipowicz@umed.lodz.pl
ligands
Synthesis, SAR &
pharmacology of H1R, H3R
& H4R antagonists
medina@uma.es Basic oncology; Metabolic
systems in pathophysiology;
Polyamines & biogenic
amines
amoyag@uma.es Computational structural
biology; Molecular
modeling; Systems Biology;
Histamine-polyamines
interplay
exfanosv@savba.sk H4R in activated
neutrophils & in rheumatoid
polyarthritis
26. Pozzoli Cristina University of Parma, IT cristina.pozzoli@unipr.it Gastrointestinal
pharmacology
27. Rajtar Simona University of Ljubljana, rajtars@yahoo.com Histamine
SI
pharmacokinetics
28. Rayan Anwar QRC-Qasemi Research a_rayan@qsm.ac.il Bioinformatics;
Center, IL
Chemoinformatics
29. Sander Kerstin Johann Wolfgang Sander@em.uni-frankfurt.de Medical chemistry of H4R
Goethe University,
Frankfurt, DE
ligands
30. Sasse Astrid Trinity College Dublin, sassea@tcd.ie Drug discovery; Medicinal
IE
chemistry
31. Seifert Roland Medical School of seifert.roland@mh-
Molecular analysis of
Hannover, DE
hannover.de
histamine receptors & Gproteins
32. Smit Martine VU University
Amsterdam, NL
smit@few.vu.nl
33. Stark Holger Johann Wolfgang h.stark@pharmchem.uni- Medical chemistry; Drug
Goethe University, frankfurt.de
design, synthesis &
Frankfurt, DE
evaluation; Imaging
34. Staszewski Marek Medical University of marek.staszewski@umed.lod Synthesis, SAR &
Lodz, PL
z.pl
pharmacology of H1R, H3R
& H4R antagonists
35. Tiligada Ekaterini University of Athens aityliga@med.uoa.gr Histamine in
Medical School, GR
immunopharmacology &
inflammation
36. Vischer Henry VU University
vischer@few.vu.nl Molecular receptor
Amsterdam, NL
pharmacology
37. Walczyński
Medical University of krzysztof.walczynski@umed.l Synthesis, SAR &
Krzysztof
Lodz, PL
odz.pl
pharmacology of H1R, H3R
& H4R antagonists
38. Walsh J. John Trinity College Dublin, jjwalsh@tcd.ie Design synthesis &
IE
evaluation in allergy, cancer
& malaria
39. Walter Miriam Johann Wolfgang Walter@pharmchem.uni- Synthesis of H3R & H4R
Goethe University, DE frankfurt.de
ligands
40. Zampeli Evangelia University of Athens
Medical School, GR
zampevi@yahoo.gr Histamine in inflammation
[2] - 6.4.2010 – WG3 Members